BSD tests improved microwave therapy for deep-body cancers
This article was originally published in Clinica
Executive Summary
BSD Medical is pressing on with its bid for US market approval of a noninvasive microwave energy-based hyperthermia system for treating cancers located deep in the body, after obtaining FDA clearance to test an improved version of the product.